APW
VRTX icon

Aventura Private Wealth’s Vertex Pharmaceuticals VRTX Stock Holding History

Aventura Private Wealth’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$26.8K Hold
54
– – 0.01% 437
2026
Q1 		$24.1K Hold
54
– – 0.01% 424
2025
Q4 		$24.5K Buy
54
+2
+4% +$862 0.01% 385
2025
Q3 		$20.4K Hold
52
– – 0.01% 397
2025
Q2 		$23.1K Hold
52
– – 0.01% 363
2025
Q1 		$25.2K Hold
52
– – 0.01% 329
2024
Q4 		$20.9K Buy
+52
New +$24.1K 0.01% 348

Other funds holding VRTX

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
BHIA
Birch Hill Investment Advisors Boston, Massachusetts $2.47B AUM 20.95% 1-Year Est. Return
CTB
Country Trust Bank Bloomington, Illinois $5.71B AUM 25.48% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return
GIA
Gateway Investment Advisers Cincinnati, Ohio $10.1B AUM 40.26% 1-Year Est. Return
II
IFM Investors Melbourne, Australia $15.1B AUM 40.57% 1-Year Est. Return

Aventura Private Wealth's VRTX Position: Q2 2026 in Review

Aventura Private Wealth held its Vertex Pharmaceuticals (VRTX) position steady in Q2 2026 at 54 shares worth $26.8K. The position accounts for 0.01% of the portfolio, ranked #437.

Aventura Private Wealth first reported a position in VRTX in Q4 2024 and has held it in 7 quarters since. 334 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • Aventura Private Wealth held 54 shares of Vertex Pharmaceuticals worth $26.8K as of Q2 2026.
  • Aventura Private Wealth left its Vertex Pharmaceuticals share count unchanged in Q2 2026.
  • Vertex Pharmaceuticals made up 0.01% of Aventura Private Wealth's portfolio in Q2 2026, its #437 holding.
  • Aventura Private Wealth first reported a position in Vertex Pharmaceuticals in Q4 2024 and has held it in 7 quarters since.
  • 334 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Aventura Private Wealth's 13F filing for Q2 2026, filed 15 Jul 2026.